JEFFREY BUTTS: Open Payments
NPI 1831246842 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,588 in 63 payments from 11 companies in 2025. Trend: 2023 $426 · 2024 $926 · 2025 $1,588
Food & beverage: $1,588
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 15 | $413 |
| Neurocrine BioSciences, Inc. | 13 | $287 |
| Indivior Inc. | 11 | $277 |
| Lundbeck LLC | 9 | $203 |
| Braeburn Inc. | 3 | $167 |
| Alkermes, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
Products named: Auvelity, INGREZZA, SUBLOCADE, REXULTI, BRIXADI, ABILIFY ASIMTUFII, VIVITROL, VRAYLAR.
Industry payments across TX — which companies pay providers there.
